SDCBP and malignant colon neoplasm: Although not directly tested in HT29, the same study also illustrated a role for syndecan-2-syntenin interaction in the migratory potential of colon cancer cells, an observation directly in favor of our hypothesis that syntenin effects in cancer cells are primarily due to its effects on syndecan metabolism.